Remarkably, high expression of EREG was suggested to fuel an oncogenic feedback loop that activates the EGFR/ERBB4 signaling cascade and was anticipated to be a therapeutic target in NSCLC [79]. The gene discussed is EREG; the disease is non-small cell lung carcinoma.